Risk of Perinatal and Maternal Morbidity and Mortality Among Pregnant Women With Epilepsy
Authors:
Open Access
- 1 September 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 81 (9) , 985-995
Abstract
Epilepsy is a common neurologic disorder affecting 65 million individuals worldwide and an estimated 0.5% to 1.0% of all pregnancies occur among women with epilepsy.1,2 Pregnancy complications among women with epilepsy extend beyond the effects of antiseizure medication (ASM) on the fetus and these complications can lead to substantial maternal and perinatal morbidity and mortality.3-6 In fact, women with epilepsy are at an increased risk of death in pregnancy and in the postpartum period.7,8Keywords
This publication has 43 references indexed in Scilit:
- Comparison of Perinatal Outcomes for Women With and Without EpilepsyJAMA Neurology, 2023
- Detailed Maternal Mortality Data Suggest More Than 4 in 5 Pregnancy-Related Deaths in US Are PreventableJAMA, 2022
- Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual DisabilityJAMA Neurology, 2022
- Maternal deaths with epilepsy: A population-based study in TurkeyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2021
- Association Between Pregnancy and Perinatal Outcomes Among Women With EpilepsyJAMA Neurology, 2017
- Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United StatesJAMA Neurology, 2015
- Population-Level Evidence for an Autoimmune Etiology of EpilepsyJAMA Neurology, 2014
- Confounding by Indication and Related ConceptsCurrent Epidemiology Reports, 2014
- Validation of epilepsy diagnoses in the Danish National Hospital RegisterEpilepsy Research, 2007
- The continuum of maternal morbidity and mortality: Factors associated with severityAmerican Journal of Obstetrics and Gynecology, 2004